Efficacy and Safety of Ciprofol for General Anesthesia in Transcatheter Aortic Valve Replacement: A Study Protocol for a Randomized Controlled Trial

Author:

ni tingting1ORCID,ni tingting2,wu shuguang2,lv tao2,Yao Yuan-yuan2,Luo Ge2,Gao Qi2,Wang Ting-ting2,Yan Min2ORCID

Affiliation:

1. second affiliated hospital zhejiang university

2. The Second Affiliated Hospital of Zhejiang University School of Medicine: Zhejiang University School of Medicine Second Affiliated Hospital

Abstract

Abstract Background: Patients who have gone through transcatheter aortic valve replacement (TAVR) and have experienced a decrease in physical and physiological capabilities are more likely to experience unfavorable cardiovascular reactions, including hypotension during induction of anesthesia. Due to the impaired cardiac function of these patients, maintaining hemodynamic stability during anesthesia induction can be challenging. Ciprofol, a novel anesthetic and a version of propofol, brings about a speedy onset, a brief recovery time, reduced injection pain, and consistent cardiorespiratory functioning. This study aims to investigate the effectiveness and safety of ciprofol in induction and maintaining general anesthesia in patients undergoing TAVR to establish its potential use in clinical practice. Methods: 124 elderly patients aged 65–80 undergoing elective TAVR with general anesthesia will be randomly assigned to two parallel groups in this single-center trial. Patients will be randomly allocated to receive either ciprofol or propofol for induction. The primary outcome is the area under the baseline of the mean arterial pressure (MAP) over the first 15 minutes after induction. Hypotension will be identified as a decrease in MAP below 65 mmHg or more than 20% from the initial value during induction. Secondary outcomes include the incidence of adverse events, such as hypotension, bradycardia, nausea and vomiting, stroke, covert central nervous system injury, myocardial infarction, and acute kidney injury, as well as the cumulative doses of vasoactive drugs, the occurrence and intensity of injection pain, and ScO2 values less than 55% of the area under the curve (AUC). Discussion: This study will provide valuable information on the effectiveness and safety of ciprofol as a general anesthetic for patients undergoing TAVR. Trial registration: ClinicalTrials.gov (NCT05881291).

Publisher

Research Square Platform LLC

Reference38 articles.

1. Anesthesia and Perioperative Management of Patients Undergoing Transcatheter Aortic Valve Implantation: Analysis of 90 Consecutive Patients With Focus on Perioperative Complications;Guinot P-G;J Cardiothorac Vasc Anesth,2010

2. Temporal Trends in the Incidence and Prognosis of Aortic Stenosis;Martinsson A;Circulation,2015

3. Heart Disease and Stroke Statistics—2012 Update;Members WG;Circulation,2012

4. Anesthesia for transcatheter aortic valve implantation: an update;Rex S;Curr Opin Anaesthesiol,2013

5. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure;Ponikowski P;Rev Esp Cardiol (Engl Ed),2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3